EXCLUSIVE: Genometrix Ceases Operations, Holds onto Hope of Restarting | GenomeWeb

NEW YORK, July 6 – Out of cash, Genometrix ceased operations as of Monday, June 25, a company official told GenomeWeb.

The Woodlands, Texas-based company laid off approximately 35 employees, leaving the company with a skeleton staff of five people, said David Jorden, CFO. On that day, companies using Genometrix products were told that the company had “stopped pursuing to completion existing service contracts,” said Jorden.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.